Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

New genes found linked to balding, may help develop future treatments.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormonal therapies are safe and effective for treating adult women's acne.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Prolactin may be important for skin growth and immune function.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Androgens may block hair growth signals, targeting this could treat hair loss.